MRI INVESTIGATIONS
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $21,029 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $21,029 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PROSPECTIVE MULTICENTER COHORT STUDY EVALUATING THE LONG TERM RETENTION OF GADOLINIUM IN HUMAN BONE AND SKIN AFTER THE RETROSPECTIVE ADMINISTRATION OF MULTIHANCE OR PROHANCE IN COMPARISON WITH A CONTROL GROUP RECEIVING NO EXPOSURE TO GADOLINIUM | BRACCO DIAGNOSTICS INC. | $21,029 | 0 |
Top Doctors Receiving Payments for MRI INVESTIGATIONS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $21,029 | 1 |
Manufacturing Companies
- BRACCO DIAGNOSTICS INC. $21,029
Product Information
- Type Drug
- Total Payments $21,029
- Total Doctors 0
- Transactions 1
About MRI INVESTIGATIONS
MRI INVESTIGATIONS is a drug associated with $21,029 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is BRACCO DIAGNOSTICS INC..
Payment data is available from 2018 to 2018. In 2018, $21,029 was paid across 1 transactions to 0 doctors.
The most common payment nature for MRI INVESTIGATIONS is "Unspecified" ($21,029, 100.0% of total).
MRI INVESTIGATIONS is associated with 1 research study, including "A PROSPECTIVE MULTICENTER COHORT STUDY EVALUATING THE LONG TERM RETENTION OF GADOLINIUM IN HUMAN BONE AND SKIN AFTER THE RETROSPECTIVE ADMINISTRATION OF MULTIHANCE OR PROHANCE IN COMPARISON WITH A CONTROL GROUP RECEIVING NO EXPOSURE TO GADOLINIUM" ($21,029).